scholarly article | Q13442814 |
P50 | author | Jacob Strahilevitz | Q104980952 |
P2093 | author name string | Amos Adler | |
Nathan Keller | |||
Colin Block | |||
Violeta Temper | |||
Gillian Smollan | |||
P2860 | cites work | mlstdbNet - distributed multi-locus sequence typing (MLST) databases | Q24803948 |
Ciprofloxacin-resistant Neisseria meningitidis, Delhi, India | Q33776644 | ||
Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli. | Q33976675 | ||
Genetic organization and regulation of antimicrobial efflux systems possessed by Neisseria gonorrhoeae and Neisseria meningitidis. | Q34231120 | ||
qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States | Q34973794 | ||
Forty years of meningococcal disease in Israel: 1951-1990. | Q39408897 | ||
Emergence of fluoroquinolone-resistant Neisseria meningitidis--Minnesota and North Dakota, 2007-2008. | Q44817882 | ||
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Neisseria meningitidis | Q154625 |
P304 | page(s) | 1667-1669 | |
P577 | publication date | 2008-10-01 | |
P1433 | published in | Emerging Infectious Diseases | Q5235761 |
P1476 | title | Serogroup A Neisseria meningitidis with reduced susceptibility to ciprofloxacin | |
P478 | volume | 14 |
Q37144776 | Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives |
Q43250356 | Antibiotic susceptibility of invasive Neisseria meningitidis isolates from 1995 to 2008 in Sweden--the meningococcal population remains susceptible |
Q38402991 | Ciprofloxacin-resistant Neisseria meningitidis in Canada: likely imported strains |
Q34627129 | Emerging resistance in Neisseria meningitidis and Neisseria gonorrhoeae |
Q37998398 | Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example |
Q36757569 | Target gene sequencing to define the susceptibility of Neisseria meningitidis to ciprofloxacin |
Search more.